Vima Therapeutics (Series A)

Funding Details

Awarder

RSS - feeds.feedburner.com

Date Award

June 06, 2025

Vertical

Biotechnology

Funding URL

View Funding Page

Funding Amount:

$60,000,000

---

Company Info

Company Description

Vima Therapeutics is a clinical-stage biotechnology company focused on oral therapies for movement disorders, advancing VIM0423, a potential first-in-class oral therapy for dystonia that targets the underlying cause in the central nervous system.

Market

Movement Disorders

Location

Cambridge, MA, USA

Coinvestors

Access Industries, Canaan

---

Links